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Evidenc  suggests that medical service offerings vary by hospital teaching status. 
However, little is known about how these translate to patient outcomes. We therefore 
sought to evaluate this gap in knowledge in patients undergoing Transcatheter aortic 
valve replacement (TAVR) in the United States.  
Methods:  
This study was conducted using the National Inpatient Sample (NIS) in the United States 
from 2011 to 2014. Teaching status was classified, as teaching vs. non-teaching and 
endpoints were clinical outcomes, length of stay and cost. Procedure-related 
complications were identified via ICD-9 coding and analysis was performed via mixed 
effect model. 
Results: 
An estimated 33,790 TAVR procedures were performed in the U.S between 2011 and 
2014, out of which 89.3% were in teaching hospitals. Mean (SD) age was 81.4 (8.5) and 
47% were females. There was no significant difference between teaching versus non-
teaching hospitals in regards to the primary outcome of in-hospital mortality and 
secondary outcomes of several cardiovascular and other end points except for a high rates 
of acute kidney injury (AKI) (OR: 1.34 [95% CI, 1.04-1.72]) and lower rate for use of 
mechanical circulatory support devices in teaching vs. non-teaching centers. The mean 
length of stay was significantly higher in teaching hospitals (7.7 days) vs. non-teaching 
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hospitals (6.8 days) (P=0.002) and so was the median cost of hospitalization (USD 
50,814 vs. USD 48, 787, P=0.02) for teaching vs. non-teaching centers.    
Conclusion: 
Most TAVR related short-term outcomes including all cause in-hospital mortality are 
about the same in teaching and non-teaching hospitals. However, AKI, length of hospital 
stay and TAVR related cost were significantly higher in teaching than non-teaching 
hospitals. There was more use of mechanical circulatory support in non-teaching than 
teaching hospitals.  
Introduction 
 
               Transcatheter aortic valve replacement (TAVR) has become the standard of care 
in appropriate high and intermediate surgical risk patients with severe symptomatic aortic 
stenosis (1). Since its advent, the volume of patients undergoing TAVR has been 
increasing with concomitant improvement in outcomes and in-hospital mortality (2). 
However, certain complications such as vascular, cardiac, neurological, respiratory, renal, 
and even death remain (3). In a concerted attempt to mitigate complications and improve 
outcomes, a multidisciplinary heart team approach mainly comprising dedicated invasive 
and non-invasive cardiologists and cardiac surgeons in the establishment of a structural 
heart disease interventional program has been proposed (4). The large majority of such 
programs initially emerged in teaching centers and a few in non-teaching centers.  
In-hospital mortality and rates of complications post TAVR were compared in 
teaching vs. non-teaching U.S centers in a prior study that reported a lower rate of in-
hospital complications in teaching vs. non-teaching centers (42% vs. 50% respectively, 
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P<0.001) (5). However, these outcomes reflect only one-year data from 2012 when only 
very few non-teaching centers had TAVR programs.  We sought to explore the evolution 
of this important theme in a more comprehensive four-year TAVR outcome analysis 
using data from the NIS registry (2011 to 2014).    
Methods 
Data source 
Study was conducted using the NIS of the Health Care Utilization Project (HCUP). 
Details of the design and description of the NIS is available online (https://www.hcup-
us.ahrq.gov/nisoverview.jsp). In brief, NIS is the largest national database representative 
of all hospital discharges in the United States since 1998. It is a 20% stratified sampling 
of discharges from U.S. community hospitals, excluding rehabilitation and long-term 
acute care hospitals. Each year, over 7 million hospital stays are sampled nationwide 
which, when weighted, estimates more than 35 million hospitalizations per year.  
Patient population 
Our study utilizes information on adult patients (age ≥ 18 years) who underwent TAVR 
across the United States between 2011 and 2014. Only patients who underwent 
endovascular (i.e. trans-femoral or trans-aortic) approach were included. Patients who 
underwent the transapical route were excluded due to available evidence indicating a 
significant difference in the pattern and rate of procedure-related outcomes compared to 
the transfemoral route (6, 7, 8).  In addition, recent evidence from the STS/ACC TAVR 
registry indicates a declining trend in the use of the transapical approach (9). Patients 
were identified using International Classification of Diseases-Ninth Revision, Clinical 
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Modification (ICD-9-CM) procedure code 35.05. Patients were then classified into 2 
major groups based on the teaching status as teaching and non-teaching centers. Baseline 
characteristics and post-procedure outcomes were compared between the two groups.  
Covariates 
Data on patient and hospital-level characteristics were provided for each patient in the 
NIS. However, identifiable variables were not included in order to preserve both patient 
and hospital privacy.. Patient-level factors including demographics, diagnoses, co-
morbidities, in-hospital procedures, disposition etc., as well as hospital level factors 
including bed-size, location, total number of hospitalizations etc. were available via the 
NIS database 
Endpoints 
The primary endpoint was in-hospital mortality defined as death at any time during the 
index hospitalization; secondary endpoints were post TAVR complications including 
acute myocardial infarction, neurologic complications, acute kidney injury, pacemaker 
placement, mechanical circulatory support, cardiac complications, vascular 
complications, hemorrhage requiring transfusion, sepsis, post-op venous 
thromboembolism, respiratory complications and non-routine discharge. In addition, our 
study also examined the length of hospital stay and hospital cost. As recommended by 
HCUP, the cost of hospitalization was indirectly estimated from the hospital charge that 
was reported. Information on cost was obtained from the hospital accounting reports 
collected by the Centers for Medicare and Medicaid Services (CMS) and these were used 
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to generate hospital-specific cost-to-charge ratio that were applied to the hospital charge 
in order to estimate the cost. 
Statistical analysis 
Using the hospital-level trend (or discharge) weight provided for the NIS, we estimated 
national estimates including sum, rates and measure of central tendency. Comorbidity 
burden per hospitalization was quantified via the Elixhauser comorbidity index. To 
compare baseline patient- and hospital-level characteristics between non-teaching and 
teaching hospital, we used chi-square test for categorical variables, unpaired t-test for 
normally distributed continuous variables, and Wilcoxon rank-sum test for continuous 
variables with skewed distribution. Thereafter, we compared procedure-related outcomes 
between hospital teaching types using mixed effect models. This model enabled us to 
account for the potential correlation of observations within each hospital. As patient-level 
factors are nested within hospital-level factors, we built hierarchical model with unique 
hospital identification number as random effect in the model. Patient-level covariates 
including age, gender, Elixhauser comorbidity index, median household income, 
insurance status/expected payer, weekend admission; as well as hospital-level covariates 
including hospital bed size, hospital region and hospital location; and year of data 
collection were adjusted for in a multivariable analysis. Difference in cost and length of 
stay was evaluated via linear mixed model while other outcomes were evaluated via 
logistic mixed effect model. We performed complete case analysis using only 
observations with non-missing values for all the variables involved in the analyses, and 
analyses were performed using STATA 14 (StataCorp, College Station, Texas) with level 
of significance set at 0.05.  
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               From 2011-2014 a total of 33,790 transfemoral and transaortic TAVR 
procedures were performed in the United States. The overwhelming majority of TAVR 
procedures were performed in teaching centers (89.3%) (Figure 1). There was a steady 
increase in the proportion of TAVR volumes in non-teaching hospitals from 2011 to 2013 
but a slight decline from 2013 to 2014. There was no significant difference in the mean 
age or gender distribution between teaching and non-teaching hospitals. More patients 
had Elixhauser comorbidity index ≥4 (53.4% in teaching centers vs. 48.0 % in non-
teaching centers) (Table 1). There was no significant difference in the rates of primary 
outcome (all cause in-hospital mortality) (OR 1.03 and (95% CI 0.70, 1.47) between 
teaching vs. non-teaching hospitals. The mean lengths of hospital stay (7.7 days vs. 6.7 
days (P= 0.002)) and cost of hospitalizations (USD 50,814 vs. USD 48, 787 (P=0.02) 
were higher for teaching centers versus non-teaching centers (Figures 2). When we 
evaluated secondary endpoints, use of mechanical circulatory support was significantly 
lower in teaching hospital (OR 0.69 (95% CI 0.47, 0.99) while rate of acute kidney 
injuries (AKI) was higher in teaching centers OR 1.34 (95% CI 1.04, 1.72). However, 
there was no significant difference between the two hospital teaching statuses for all 
other secondary endpoints  (Figures 3 & 4). 
Discussion 
               The salient findings of our study may be summarized as follows: I) The primary 
outcome of all cause in-hospital mortality post TAVR was not significantly different 
between teaching and non-teaching hospitals, II) The secondary outcomes of post TAVR 
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complications including acute myocardial infarction, neurologic complications, 
pacemaker placement, cardiac complications, vascular complications, hemorrhage 
requiring transfusion, sepsis, post-op venous thromboembolism, respiratory 
complications and non-routine discharge post TAVR did not differ significantly between 
teaching and non-teaching hospitals. III) Teaching hospital status was associated with 
higher risk of AKI and lower rates for use of mechanical circulatory support. IV) In 
teaching hospitals mean length of stay and median cost of hospitalization were 
significantly higher compared with non-teaching hospitals. 
               Our findings are consistent with the findings of a previous study by Pant et al, 
who analyzed 7,405 TAVR procedures from the NIS performed in 2012 and also found 
no significant difference in all-cause in-hospital mortality. However, unlike our study, the 
previous study from 2012 showed lower rates of TAVR related complications in teaching 
vs. non-teaching hospitals in the United States. Our study suggests that over the years, the 
difference in the rates of major TAVR related complications between teaching and non-
teaching hospitals has narrowed considerably. This may be possibly explained by an 
increase in procedural volumes and operator expertise with ensuing reductions in 
complication rates, in non-teaching hospitals. This contrasting observation, deviating 
significantly from a prior report is a notable addition to the existing body of literature. 
Currently available data on the impact of teaching status on in-hospital outcomes after 
interventional cardiology procedures are limited. Our data demonstrated that the majority 
of TAVR patients were seen in teaching hospitals, consistent with a higher volume of 
procedures performed in these institutions.  
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               Operator and hospital volumes have been shown to be inversely related to 
complications post TAVR as indicated by a previous analyses of in-hospital outcomes 
(10). However, the Centers of Medicare & Medicaid Services established specific 
procedural volume requirements that hospitals with and without TAVR experience must 
meet. Specifically, the initiation of a TAVR program requires ≥ 50 aortic valve 
replacements, ≥ 1000 catheterizations and ≥ 400 percutaneous coronary interventions in 
the year prior to TAVR initiation (11). Therefore, teaching and non-teaching hospitals are 
now expected to have similar case volumes and experience with interventional cardiology 
and cardiothoracic surgery procedures in order to begin and continue a TAVR program. 
               Differences not only in volume but also implementation of guidelines and 
appropriate use criteria can positively impact patient-related outcomes. Registry data 
suggest variations in performance measures in teaching vs. non-teaching hospitals with 
greater adherence to standard guidelines for cardiovascular diseases, such as coronary 
artery disease and heart failure in teaching vs. non-teaching hospitals (12, 13). However, 
recent registry data suggest no significant association between hospital teaching status 
and adherence to guidelines among hospitals enrolled in the “Get With The Guidelines”–
Heart Failure program (14). These findings may be due to gradually increasing emphasis 
on implementation of protocolized guidelines, metrics and performance indicators for 
evaluation of comprehensive care delivery.  
               In addition to educational and research responsibilities, teaching hospitals are 
typically located in urban settings, serving populations with a lower socioeconomic and 
educational status and provide care as tertiary referral centers to patients with 
complicated cardiac conditions and multiple comorbidities. These factors in combination 
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with the participation of less experienced physicians-in-training could plausibly lead to 
worse clinical outcomes and potentially slightly longer and more expensive 
hospitalizations as seen in our analysis. Although, we did not identify significant 
differences in the demographic characteristics or the comorbidity burden, our results 
should be interpreted with caution as many potential confounders may be unmeasured 
and missing. 
               The lack of difference in mortality between teaching and non-teaching hospitals 
was demonstrated in a meta-analysis of 132 observational cohort studies. However, the 
authors observed large between-study heterogeneity that precluded meaningful 
conclusion about other non-fatal outcomes (15). Therefore, based on the evidence 
summarized above, the focus should be shifted away from identification of differences in 
mortality and other hard cardiovascular outcomes between teaching and non-teaching 
hospitals but instead concentrated towards implementation of guidelines, appropriate use 
criteria, utilization of standardized quality measures and reduction of TAVR-related 
health care expenditures. Most importantly, although teaching in a healthcare facility 
does not seem to directly improve short-term patient outcomes, it is an integral part of 
cardiology, improves the level of knowledge and experience of future physicians in both 
teaching and non-teaching hospitals and as such should be strongly encouraged and 
supported. 
               Potential limitations of our study should also be considered. First, due to the 
observational nature of the study, we cannot claim a causal link between teaching status 
and any of the endpoints because other unmeasured covariates may have contributed to 
this association. However, we limited the potential bias in the associations by adjusting 
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for multiple patient- and hospital-level covariates that might have confounded the 
associations. Second, our analysis was limited to in-patient data and, hence, we are not 
able to make any inference about patient outcomes in the immediate post-discharge 
period that may be related to in-patient care. Despite these limitations, NIS remains a 
large, easily accessible dataset that has been widely used to estimate national trends in in-
patient outcomes. 
Conclusion 
               We found no substantial differences between teaching and non-teaching 
hospitals in regards to in-hospital mortality and other procedure-related complications 
post TAVR. However, we identified high rates of post TAVR AKI, longer hospital stay 
and higher cost of hospitalization in teaching centers. The use of mechanical circulatory 
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Table 1. Baseline characteristics of patient hospitalized for TAVR, stratified by hospital 
teaching status.  
TAVR: Transcatheter aortic valve replacement  
PVD: Peripheral vascular disease  
Figure 1. Trend in percentage of TAVR procedures performed per year between non-
teaching and teaching hospitals (2011-2014). 
TAVR: Transcatheter aortic valve replacement  
Figure 2. Cost of hospitalization for TAVR between hospital teaching status (p for 
difference=0.02) 
USD: United States dollars 
Figure 3: Rates (%) of TAVR-associated complications 
Acute MI: Acute Myocardial infarction 
DVT/PE: Deep vein thrombosis/Pulmonary embolism 
Figure 4. Comparing TAVR-associated complications between teaching and non-
teaching hospital 
DVT/PE: Deep vein thrombosis/Pulmonary embolism 
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Table 1.  Baseline characteristics of patients hospitalized for 
transcatheter aortic valve replacement, stratified by hospital teaching 
status 
 Total  Non-teaching  Teaching   P value 
Unweighted No. (%) 6,778 (100) 727 (10.7) 6,051 (89.3)  
Weighted No. (%) 33,790 (100) 3,621 (10.7) 30,169 (89.3)  
Age, mean (SD) 81.4 (8.5) 81.5 (8.3) 81.4 (8.6) 0.59 
Female, % 46.1 44.8 46.1 0.49 
Race, %     
  White 87.4 92.0 86.8  
  Black 4.1 2.5 4.4  
  Hispanic 3.4 1.3 3.6 <0.001 
  Asia 1.1 1.3 1.0  
  Others 4.1 2.9 4.2  
Obesity, % 14.6 13.5 14.7 0.37 
Diabetes, % 34.9 33.8 35.0 0.55 
PVD, % 28.2 23.5 28.7 0.003 
Hypertension, % 79.6 76.6 79.9 0.04 
Congestive heart failure, % 12.8 11.4 13.0 0.24 
Chronic lung disease, % 32.6 29.0 33.0 0.03 
Renal failure, % 36.7 39.8 36.3 0.06 
Liver disease, % 2.7 2.1 2.8 0.26 
Cerebrovascular disease, % 10.0 9.9 10.1 0.86 
Rheumatologic disease, % 4.8 4.8 4.8 0.98 
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Elixhauser comorbidity index, 
% 
    
0-1 9.6 12.4 9.2  
2-3 37.6 39.6 37.4 0.004 
≥4 52.8 48.0 53.4  
Median household income, %      
1
st
 quartile 20.7 22.0 20.6  
2
nd
 quartile 24.9 31.5 24.1 <0.001 
3
rd
 quartile 25.5 22.7 25.9  
4
th
 quartile 28.9 23.8 29.5  
Hospital bed size, %     
Small 4.3 12.8 3.3  
Medium 15.5 23.5 14.5 <0.001 
Large 80.2 63.7 82.2  
Hospital region, %     
Northeast 25.7 13.9 27.1  
Midwest 22.3 25.6 22.0 <0.001 
South 34.4 41.1 33.6  
West 17.6 19.4 17.3  
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Figure 1. Trend in percentage of TAVR procedures performed per year between non-teaching and teaching 
hospitals (2011-2014).  
TAVR: Transcatheter aortic valve replacement  
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Figure 2. Cost of hospitalization for TAVR between hospital teaching status (p for difference=0.02)  
USD: United States dollars  
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Figure 3: Rates (%) of TAVR-associated complications  
Acute MI: Acute Myocardial infarction  
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Figure 4. Comparing TAVR-associated complications between teaching and non-teaching hospital 
 
DVT/PE: Deep vein thrombosis/Pulmonary embolism 
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Evidenc  suggests that medical service offerings vary by hospital teaching status. 
However, little is known about how these translate to patient outcomes. We therefore 
sought to evaluate this gap in knowledge in patients undergoing Transcatheter aortic 
valve replacement (TAVR) in the United States.  
Methods:  
This study was conducted using the National Inpatient Sample (NIS) in the United States 
from 2011 to 2014. Teaching status was classified, as teaching vs. non-teaching and 
endpoints were clinical outcomes, length of stay and cost. Procedure-related 
complications were identified via ICD-9 coding and analysis was performed via mixed 
effect model. 
Results: 
An estimated 33,790 TAVR procedures were performed in the U.S between 2011 and 
2014, out of which 89.3% were in teaching hospitals. Mean (SD) age was 81.4 (8.5) and 
47% were females. There was no significant difference between teaching versus non-
teaching hospitals in regards to the primary outcome of in-hospital mortality and 
secondary outcomes of several cardiovascular and other end points except for a high rates 
of acute kidney injury (AKI) (OR: 1.34 [95% CI, 1.04-1.72]) and lower rate for use of 
mechanical circulatory support devices in teaching vs. non-teaching centers. The mean 
length of stay was significantly higher in teaching hospitals (7.7 days) vs. non-teaching 
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hospitals (6.8 days) (P=0.002) and so was the median cost of hospitalization (USD 
50,814 vs. USD 48, 787, P=0.02) for teaching vs. non-teaching centers.    
Conclusion: 
Most TAVR related short-term outcomes including all cause in-hospital mortality are 
about the same in teaching and non-teaching hospitals. However, AKI, length of hospital 
stay and TAVR related cost were significantly higher in teaching than non-teaching 
hospitals. There was more use of mechanical circulatory support in non-teaching than 
teaching hospitals.  
Introduction 
 
               Transcatheter aortic valve replacement (TAVR) has become the standard of care 
in appropriate high and intermediate surgical risk patients with severe symptomatic aortic 
stenosis (1). Since its advent, the volume of patients undergoing TAVR has been 
increasing with concomitant improvement in outcomes and in-hospital mortality (2). 
However, certain complications such as vascular, cardiac, neurological, respiratory, renal, 
and even death remain (3). In a concerted attempt to mitigate complications and improve 
outcomes, a multidisciplinary heart team approach mainly comprising dedicated invasive 
and non-invasive cardiologists and cardiac surgeons in the establishment of a structural 
heart disease interventional program has been proposed (4). The large majority of such 
programs initially emerged in teaching centers and a few in non-teaching centers.  
In-hospital mortality and rates of complications post TAVR were compared in 
teaching vs. non-teaching U.S centers in a prior study that reported a lower rate of in-
hospital complications in teaching vs. non-teaching centers (42% vs. 50% respectively, 
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P<0.001) (5). However, these outcomes reflect only one-year data from 2012 when only 
very few non-teaching centers had TAVR programs.  We sought to explore the evolution 
of this important theme in a more comprehensive four-year TAVR outcome analysis 
using data from the NIS registry (2011 to 2014).    
Methods 
Data source 
Study was conducted using the NIS of the Health Care Utilization Project (HCUP). 
Details of the design and description of the NIS is available online (https://www.hcup-
us.ahrq.gov/nisoverview.jsp). In brief, NIS is the largest national database representative 
of all hospital discharges in the United States since 1998. It is a 20% stratified sampling 
of discharges from U.S. community hospitals, excluding rehabilitation and long-term 
acute care hospitals. Each year, over 7 million hospital stays are sampled nationwide 
which, when weighted, estimates more than 35 million hospitalizations per year.  
Patient population 
Our study utilizes information on adult patients (age ≥ 18 years) who underwent TAVR 
across the United States between 2011 and 2014. Only patients who underwent 
endovascular (i.e. trans-femoral or trans-aortic) approach were included. Patients who 
underwent the transapical route were excluded due to available evidence indicating a 
significant difference in the pattern and rate of procedure-related outcomes compared to 
the transfemoral route (6, 7, 8).  In addition, recent evidence from the STS/ACC TAVR 
registry indicates a declining trend in the use of the transapical approach (9). Patients 
were identified using International Classification of Diseases-Ninth Revision, Clinical 
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Modification (ICD-9-CM) procedure code 35.05. Patients were then classified into 2 
major groups based on the teaching status as teaching and non-teaching centers. Baseline 
characteristics and post-procedure outcomes were compared between the two groups.  
Covariates 
Data on patient and hospital-level characteristics were provided for each patient in the 
NIS. However, identifiable variables were not included in order to preserve both patient 
and hospital privacy.. Patient-level factors including demographics, diagnoses, co-
morbidities, in-hospital procedures, disposition etc., as well as hospital level factors 
including bed-size, location, total number of hospitalizations etc. were available via the 
NIS database 
Endpoints 
The primary endpoint was in-hospital mortality defined as death at any time during the 
index hospitalization; secondary endpoints were post TAVR complications including 
acute myocardial infarction, neurologic complications, acute kidney injury, pacemaker 
placement, mechanical circulatory support, cardiac complications, vascular 
complications, hemorrhage requiring transfusion, sepsis, post-op venous 
thromboembolism, respiratory complications and non-routine discharge. In addition, our 
study also examined the length of hospital stay and hospital cost. As recommended by 
HCUP, the cost of hospitalization was indirectly estimated from the hospital charge that 
was reported. Information on cost was obtained from the hospital accounting reports 
collected by the Centers for Medicare and Medicaid Services (CMS) and these were used 
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to generate hospital-specific cost-to-charge ratio that were applied to the hospital charge 
in order to estimate the cost. 
Statistical analysis 
Using the hospital-level trend (or discharge) weight provided for the NIS, we estimated 
national estimates including sum, rates and measure of central tendency. Comorbidity 
burden per hospitalization was quantified via the Elixhauser comorbidity index. To 
compare baseline patient- and hospital-level characteristics between non-teaching and 
teaching hospital, we used chi-square test for categorical variables, unpaired t-test for 
normally distributed continuous variables, and Wilcoxon rank-sum test for continuous 
variables with skewed distribution. Thereafter, we compared procedure-related outcomes 
between hospital teaching types using mixed effect models. This model enabled us to 
account for the potential correlation of observations within each hospital. As patient-level 
factors are nested within hospital-level factors, we built hierarchical model with unique 
hospital identification number as random effect in the model. Patient-level covariates 
including age, gender, Elixhauser comorbidity index, median household income, 
insurance status/expected payer, weekend admission; as well as hospital-level covariates 
including hospital bed size, hospital region and hospital location; and year of data 
collection were adjusted for in a multivariable analysis. Difference in cost and length of 
stay was evaluated via linear mixed model while other outcomes were evaluated via 
logistic mixed effect model. We performed complete case analysis using only 
observations with non-missing values for all the variables involved in the analyses, and 
analyses were performed using STATA 14 (StataCorp, College Station, Texas) with level 
of significance set at 0.05.  
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               From 2011-2014 a total of 33,790 transfemoral and transaortic TAVR 
procedures were performed in the United States. The overwhelming majority of TAVR 
procedures were performed in teaching centers (89.3%) (Figure 1). There was a steady 
increase in the proportion of TAVR volumes in non-teaching hospitals from 2011 to 2013 
but a slight decline from 2013 to 2014. There was no significant difference in the mean 
age or gender distribution between teaching and non-teaching hospitals. More patients 
had Elixhauser comorbidity index ≥4 (53.4% in teaching centers vs. 48.0 % in non-
teaching centers) (Table 1). There was no significant difference in the rates of primary 
outcome (all cause in-hospital mortality) (OR 1.03 and (95% CI 0.70, 1.47) between 
teaching vs. non-teaching hospitals. The mean lengths of hospital stay (7.7 days vs. 6.7 
days (P= 0.002)) and cost of hospitalizations (USD 50,814 vs. USD 48, 787 (P=0.02) 
were higher for teaching centers versus non-teaching centers (Figures 2). When we 
evaluated secondary endpoints, use of mechanical circulatory support was significantly 
lower in teaching hospital (OR 0.69 (95% CI 0.47, 0.99) while rate of acute kidney 
injuries (AKI) was higher in teaching centers OR 1.34 (95% CI 1.04, 1.72). However, 
there was no significant difference between the two hospital teaching statuses for all 
other secondary endpoints  (Figures 3 & 4). 
Discussion 
               The salient findings of our study may be summarized as follows: I) The primary 
outcome of all cause in-hospital mortality post TAVR was not significantly different 
between teaching and non-teaching hospitals, II) The secondary outcomes of post TAVR 
Page 28 of 36
Catheterization and Cardiovascular Interventions
Catheterization and Cardiovascular Interventions











complications including acute myocardial infarction, neurologic complications, 
pacemaker placement, cardiac complications, vascular complications, hemorrhage 
requiring transfusion, sepsis, post-op venous thromboembolism, respiratory 
complications and non-routine discharge post TAVR did not differ significantly between 
teaching and non-teaching hospitals. III) Teaching hospital status was associated with 
higher risk of AKI and lower rates for use of mechanical circulatory support. IV) In 
teaching hospitals mean length of stay and median cost of hospitalization were 
significantly higher compared with non-teaching hospitals. 
               Our findings are consistent with the findings of a previous study by Pant et al, 
who analyzed 7,405 TAVR procedures from the NIS performed in 2012 and also found 
no significant difference in all-cause in-hospital mortality. However, unlike our study, the 
previous study from 2012 showed lower rates of TAVR related complications in teaching 
vs. non-teaching hospitals in the United States. Our study suggests that over the years, the 
difference in the rates of major TAVR related complications between teaching and non-
teaching hospitals has narrowed considerably. This may be possibly explained by an 
increase in procedural volumes and operator expertise with ensuing reductions in 
complication rates, in non-teaching hospitals. This contrasting observation, deviating 
significantly from a prior report is a notable addition to the existing body of literature. 
Currently available data on the impact of teaching status on in-hospital outcomes after 
interventional cardiology procedures are limited. Our data demonstrated that the majority 
of TAVR patients were seen in teaching hospitals, consistent with a higher volume of 
procedures performed in these institutions.  
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               Operator and hospital volumes have been shown to be inversely related to 
complications post TAVR as indicated by a previous analyses of in-hospital outcomes 
(10). However, the Centers of Medicare & Medicaid Services established specific 
procedural volume requirements that hospitals with and without TAVR experience must 
meet. Specifically, the initiation of a TAVR program requires ≥ 50 aortic valve 
replacements, ≥ 1000 catheterizations and ≥ 400 percutaneous coronary interventions in 
the year prior to TAVR initiation (11). Therefore, teaching and non-teaching hospitals are 
now expected to have similar case volumes and experience with interventional cardiology 
and cardiothoracic surgery procedures in order to begin and continue a TAVR program. 
               Differences not only in volume but also implementation of guidelines and 
appropriate use criteria can positively impact patient-related outcomes. Registry data 
suggest variations in performance measures in teaching vs. non-teaching hospitals with 
greater adherence to standard guidelines for cardiovascular diseases, such as coronary 
artery disease and heart failure in teaching vs. non-teaching hospitals (12, 13). However, 
recent registry data suggest no significant association between hospital teaching status 
and adherence to guidelines among hospitals enrolled in the “Get With The Guidelines”–
Heart Failure program (14). These findings may be due to gradually increasing emphasis 
on implementation of protocolized guidelines, metrics and performance indicators for 
evaluation of comprehensive care delivery.  
               In addition to educational and research responsibilities, teaching hospitals are 
typically located in urban settings, serving populations with a lower socioeconomic and 
educational status and provide care as tertiary referral centers to patients with 
complicated cardiac conditions and multiple comorbidities. Although, we did not identify 
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significant differences in the demographic characteristics or the comorbidity burden, our 
results should be interpreted with caution as many potential confounders may be 
unmeasured and missing. 
               The lack of difference in mortality between teaching and non-teaching hospitals 
was demonstrated in a meta-analysis of 132 observational cohort studies. However, the 
authors observed large between-study heterogeneity that precluded meaningful 
conclusion about other non-fatal outcomes (15). Therefore, based on the evidence 
summarized above, the focus should be shifted away from identification of differences in 
mortality and other hard cardiovascular outcomes between teaching and non-teaching 
hospitals but instead concentrated towards implementation of guidelines, appropriate use 
criteria, utilization of standardized quality measures and reduction of TAVR-related 
health care expenditures. Most importantly, although teaching in a healthcare facility 
does not seem to directly improve short-term patient outcomes, it is an integral part of 
cardiology, improves the level of knowledge and experience of future physicians in both 
teaching and non-teaching hospitals and as such should be strongly encouraged and 
supported. 
               Potential limitations of our study should also be considered. First, due to the 
observational nature of the study, we cannot claim a causal link between teaching status 
and any of the endpoints because other unmeasured covariates may have contributed to 
this association. However, we limited the potential bias in the associations by adjusting 
for multiple patient- and hospital-level covariates that might have confounded the 
associations. Second, our analysis was limited to in-patient data and, hence, we are not 
able to make any inference about patient outcomes in the immediate post-discharge 
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period that may be related to in-patient care. Despite these limitations, NIS remains a 
large, easily accessible dataset that has been widely used to estimate national trends in in-
patient outcomes. 
Conclusion 
               We found no substantial differences between teaching and non-teaching 
hospitals in regards to in-hospital mortality and other procedure-related complications 
post TAVR. However, we identified high rates of post TAVR AKI, longer hospital stay 
and higher cost of hospitalization in teaching centers. The use of mechanical circulatory 
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Table 1. Baseline characteristics of patient hospitalized for TAVR, stratified by hospital 
teaching status.  
TAVR: Transcatheter aortic valve replacement  
PVD: Peripheral vascular disease  
Figure 1. Trend in percentage of TAVR procedures performed per year between non-
teaching and teaching hospitals (2011-2014). 
TAVR: Transcatheter aortic valve replacement  
Figure 2. Cost of hospitalization for TAVR between hospital teaching status (p for 
difference=0.02) 
USD: United States dollars 
Figure 3: Rates (%) of TAVR-associated complications 
Acute MI: Acute Myocardial infarction 
DVT/PE: Deep vein thrombosis/Pulmonary embolism 
Figure 4. Comparing TAVR-associated complications between teaching and non-
teaching hospital 
DVT/PE: Deep vein thrombosis/Pulmonary embolism 
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